Roemer Alan S. 4
4 · IN8BIO, INC. · Filed Oct 8, 2024
Insider Transaction Report
Form 4
IN8BIO, INC.INAB
Roemer Alan S.
Director
Transactions
- Disposition to Issuer
Series A Warrants (right to buy)
2024-10-04−102,459→ 0 totalExercise: $1.25Exp: 2025-06-13→ Common Stock (102,459 underlying) - Award
Series A Warrants (right to buy)
2024-10-04+102,459→ 102,459 totalExercise: $0.45Exp: 2025-10-04→ Common Stock (102,459 underlying) - Award
Series C Warrants (right to buy)
2024-10-04+126,582→ 126,582 totalExercise: $0.27Exp: 2027-10-04→ Common Stock (126,582 underlying) - Award
Common Stock
2024-10-04+126,582→ 285,030 total
Footnotes (4)
- [F1]The reported securities are included within 126,582 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 126,582 shares of common stock.
- [F2]The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.
- [F3]Fully vested and exercisable.
- [F4]The reported securities are included within 102,459 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 102,459 shares of common stock.